Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Angiodynamics Inc (NQ: ANGO )

13.69 +0.08 (+0.59%)
Streaming Delayed Price Updated: 1:00 PM EST, Nov 25, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 88,077
Open 13.51
Bid (Size) 5.460 (2)
Ask (Size) 15.29 (1)
Prev. Close 13.61
Today's Range 13.50 - 13.79
52wk Range 12.87 - 30.00
Shares Outstanding 38,444,076
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Why Coupa Software Shares Jumped Around 29%; Here Are 72 Biggest Movers From Wednesday
Gainers Kalera Public Limited Company (NASDAQ: KAL) jumped 76.9% to close at $0.1610 on Wednesday after gaining 9% on Tuesday. Kalera recently posted a Q3 loss of $0.05 per share. 
Via Benzinga
Credit Suisse, Autodesk And Other Big Losers From Wednesday
U.S. stocks closed higher on Wednesday, with the Nasdaq Composite gaining more than 100 points. Here is the list of some big stocks recording losses in the previous session. 
Via Benzinga

Performance

YTD
-53.05%
-53.05%
1 Month
+2.70%
+2.70%
3 Month
-38.00%
-38.00%
6 Month
-30.26%
-30.26%
1 Year
-49.71%
-49.71%

More News

Read More
Why AngioDynamics Stock Just Crashed 12%
Via The Motley Fool
AngioDynamics Shares Fall On Lower Than Expected Q1 Earnings, Reaffirms Annual Guidance
Via Benzinga
Why PagSeguro Digital Shares Are Trading Lower By 18%? Here Are 40 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
AngioDynamics to Present at the Piper Sandler Healthcare Conference
From AngioDynamics, Inc.
Via Business Wire
AngioDynamics Announces First Patient Enrolled in APEX-AV Study Assessing AlphaVac F1885 PE System in Treatment of Pulmonary Embolism
From AngioDynamics, Inc.
Via Business Wire
AngioDynamics: Q1 Earnings Insights
Via Benzinga
Raymond James Cuts Price Target On AngioDynamics
Via Benzinga
Here's Why This Hidden Growth Stock Is a Buy
Via The Motley Fool
$20 Million Bet On Rocket Pharmaceuticals? 3 Stocks Insiders Are Buying
Via Benzinga
Constellation Brands To Rally 21%? Plus Wells Fargo Predicts $225 For Visa
Via Benzinga
Dow Dips Over 300 Points; Provention Bio Shares Spike Higher
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Why Cyclerion Therapeutics Shares Traded Lower By Around 38%; Here Are 70 Biggest Movers From Yesterday
Via Benzinga
Stocks Edge Lower As Bond Yields Rise
Via Talk Markets
Why Revelation Biosciences Shares Are Trading Higher By 29%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Nasdaq Edges Higher; AngioDynamics Shares Plummet
Via Benzinga
AngioDynamics, Resources Connection And Some Other Big Stocks Moving Lower On Thursday
Via Benzinga
AngioDynamics Reports Fiscal 2023 First Quarter Financial Results; Reaffirms Guidance
From AngioDynamics, Inc.
Via Business Wire
Earnings Scheduled For October 6, 2022
Via Benzinga
AngioDynamics's Earnings: A Preview
Via Benzinga
AngioDynamics to Report Fiscal 2023 First Quarter Financial Results on October 6, 2022
From AngioDynamics, Inc.
Via Business Wire
AngioDynamics to Present at the Canaccord Genuity Growth Conference
From AngioDynamics, Inc.
Via Business Wire
Cboe's Weekly Market Recap: July 5th to July 8th
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.